Published in J Neural Transm Suppl on January 01, 1989
Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects. Br J Clin Pharmacol (1990) 0.93
A randomized controlled trial comparing moclobemide and moclobemide plus interpersonal psychotherapy in the treatment of dysthymic disorder. J Psychother Pract Res (2001) 0.92
Monoamine oxidase-A: pharmacodynamics in humans of moclobemide, a reversible and selective inhibitor. Br J Clin Pharmacol (1994) 0.87
Moclobemide excretion in human breast milk. Br J Clin Pharmacol (1990) 0.82
The International Multicenter Clinical Trial Group on Moclobemide in Social Phobia. Moclobemide in social phobia. A double-blind, placebo-controlled clinical study. Eur Arch Psychiatry Clin Neurosci (1997) 0.81
[Pharmacokinetics of midazolam after i.v. administration (author's transl)]. Arzneimittelforschung (1981) 1.58
Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett (1980) 1.48
Bioavailability from various galenic formulations of flunitrazepam. Arzneimittelforschung (1977) 1.19
[New theoretical values in exploration of the respiratory function of the lung]. Bull Physiopathol Respir (Nancy) (1972) 1.17
Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial. Br J Psychiatry (1996) 1.15
Pharmacokinetic and clinical considerations in the choice of a hypnotic. Br J Clin Pharmacol (1983) 1.09
Increased serum glutamate in depressed patients. Arch Psychiatr Nervenkr (1970) (1982) 1.08
Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. Int Clin Psychopharmacol (2003) 1.04
Moclobemide, imipramine and placebo in the treatment of major depression. Acta Psychiatr Scand Suppl (1990) 1.03
[Relationship between clinical effects and pharmacokinetics of midazolam on i.m. and i.v. application to volunteers/1st comm.: Clinical aspects (author's transl)]. Arzneimittelforschung (1981) 1.01
Pharmacokinetic and clinical observations on prolonged administration of flunitrazepam. Eur J Clin Pharmacol (1980) 0.99
Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia. Eur J Cardiol (1979) 0.97
Pharmacology of flumazenil. Acta Anaesthesiol Scand Suppl (1995) 0.93
Saccadic eye movements in psychiatric patients. Neuropsychobiology (1983) 0.92
Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine. Br J Psychiatry (1992) 0.91
[Pharmacokinetics of soporific drugs]. ZFA (Stuttgart) (1980) 0.89
Evaluation of the efficacy and tolerance of orally administered midazolam as hypnotic agent compared with oxazepam in the treatment of insomnia of mild to moderate severity. Arzneimittelforschung (1981) 0.89
Clinical pharmacology of moclobemide during chronic administration of high doses to healthy subjects. Psychopharmacology (Berl) (1998) 0.87
Moclobemide and tricyclic antidepressants in severe depression: meta-analysis and prospective studies. J Clin Psychopharmacol (1995) 0.86
Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group. Int Clin Psychopharmacol (1997) 0.86
[New normal values for the pulmonary function test with whole body plethysmography]. Dtsch Med Wochenschr (1969) 0.84
Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine. Braz J Med Biol Res (2011) 0.84
The antihypertensive effect of lexotan (bromazepam)- a new benzodiazepine derivative. Int J Clin Pharmacol Biopharm (1977) 0.84
Postvitrectomy positioning complicated by ulnar nerve palsy. Am J Ophthalmol (1996) 0.82
Disturbed smooth pursuit and saccadic eye movements in schizophrenia. Arch Psychiatr Nervenkr (1970) (1982) 0.82
Social phobia: long-term treatment outcome and prediction of response--a moclobemide study. Int Clin Psychopharmacol (1997) 0.80
Assessment of pharmacodynamics of a new "controlled release" form of diazepam (Valium CR Roche) by quantitative EEG and psychometric analysis in neurotic subjects. J Int Med Res (1981) 0.79
RIMA--a new concept in the treatment of depression with moclobemide. Int Clin Psychopharmacol (1993) 0.79
Reduction of cerebrospinal fluid glutamic acid in Huntington's chorea and in schizophrenic patients. Arch Psychiatr Nervenkr (1970) (1980) 0.78
The therapeutic value of clonidine in patients with coronary heart disease. Eur J Cardiol (1979) 0.78
[New normal values in exploration of pulmonary function by body plethysmography]. J Fr Med Chir Thorac (1970) 0.78
Antidepressants and drug-metabolizing enzymes--expert group report. Acta Psychiatr Scand (1996) 0.78
Interactions of moclobemide with concomitantly administered medication: evidence from pharmacological and clinical studies. Psychopharmacology (Berl) (1992) 0.77
Moclobemide is effective and well tolerated in the long-term pharmacotherapy of social anxiety disorder with or without comorbid anxiety disorder. Int Clin Psychopharmacol (2002) 0.77
[Saccadic eye movements and endogenous psychoses]. Fortschr Neurol Psychiatr (1984) 0.77
Interaction of moclobemide, a new reversible monoamine oxidase inhibitor with oral tyramine. J Neural Transm Suppl (1988) 0.77
Pharmacokinetic and pharmacodynamic interactions between fluoxetine and moclobemide in the investigation of development of the "serotonin syndrome". Clin Pharmacol Ther (1998) 0.76
Effects of smoking and inhalation of carbon monoxide on systolic time intervals and blood pressure. Differences between two types of cigarettes and a cigar. Chest (1979) 0.76
Effects of amitriptyline on serum glutamate and free tryptophan in rats. Arch Psychiatr Nervenkr (1970) (1982) 0.76
[The problem of epistemology in neuroscience and its consequences to psychiatry]. Nervenarzt (2007) 0.75
Safety and efficacy during long-term treatment with moclobemide. Clin Neuropharmacol (1994) 0.75
Monoamine oxidase inhibitors, cognitive functions and neurodegenerative diseases. J Neural Transm Suppl (1994) 0.75
Antihypertensive effects of a novel peripheral vasodilator, Ro 12-4713. Eur J Clin Pharmacol (1981) 0.75
[The cerebral neocortex controls the immune system]. Bull Acad Natl Med (1982) 0.75
[Chemical laboratory studies for the internist's practice]. Schweiz Med Wochenschr (1965) 0.75
[Tests in emergency service]. Med Lab (Stuttg) (1968) 0.75
RIMA: a safe concept in the treatment of depression with moclobemide. Can J Psychiatry (1992) 0.75
[Bromazepam lowers the blood pressure in hypertensive patients]. Med Welt (1979) 0.75
[The diagnostic value of measured functional parameters in obstructive lung diseases]. Helv Med Acta Suppl (1970) 0.75
Myocardial function. Arch Intern Med (1980) 0.75
[Acute hemodynamic changes following smoking and carbon monoxide inhalation]. Ther Umsch (1980) 0.75
[Procedures for the early recognition of diabetics in Basle 1972. Contributions to the early diagnosis of diabetes mellitus by means of blood sugar analysis with special reference to the practical procedures under Swiss conditions]. Schweiz Med Wochenschr (1976) 0.75
Long-term treatment with moclobemide. An open-label, non-comparative, multiple-distributed study in patients with a major depressive episode as defined by DSM-III. Psychopharmacology (Berl) (1992) 0.75
[Demonstration of salmonella antigens in the immunodiffusion test]. Zentralbl Bakteriol Orig (1968) 0.75
A new device for testing cognitive-psychomotor functions. A line tracking apparatus (LTA) by R. Amrein. A comparative study. Blutalkohol (1988) 0.75
The sensitivity of gamma-aminobutyric acid antagonists to thiocyanate is related to the absence of a functional anionic group in their structure. Eur J Pharmacol (1987) 0.75
[Chest X-ray in the diagnosis of chronic cor pulmonale. A study of patients in stages I-II]. Schweiz Med Wochenschr (1970) 0.75
Relevance of reversible inhibitors of monoamine oxidase type A and of reuptake inhibition for noradrenaline turnover. Acta Psychiatr Scand Suppl (1995) 0.75
[Special determination of transaminases using the ultraviolet test]. Praxis (1966) 0.75
Spontaneous variation in systolic time interval. Lancet (1979) 0.75
[Lactic acidosis associated with various types of biguanide-therapy (phenformin, buformin, metformin). Results of a survey of the years 1972--1977 in Switzerland (author's transl)]. Schweiz Rundsch Med Prax (1978) 0.75
Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia. Br J Clin Pract Suppl (1980) 0.75
[Influence of protein content on total CSF protein (author's transl)]. Fortschr Neurol Psychiatr (1982) 0.75
Moclobemide: a paradigm of research in clinical psychopharmacology. Int Clin Psychopharmacol (1996) 0.75
[Chemical laboratory studies for the internist's practice]. Schweiz Med Wochenschr (1965) 0.75
Diclofensine and imipramine. A double-blind comparative trial in depressive out-patients. Neuropsychobiology (1985) 0.75
Effect of flumazenil on the electroencephalogram of patients with portosystemic encephalopathy. Results of a double blind, randomised, placebo-controlled multicentre trial. Electroencephalogr Clin Neurophysiol (1996) 0.75
Levels of total and free tryptophan in the plasma of endogenous and neurotic depressives. Arch Psychiatr Nervenkr (1970) (1981) 0.75
[On the mode of action of difenoxin (R 15 403). Part 2: Studies on the perfused isolated colonic loop of the rat (author's transl)]. Arzneimittelforschung (1976) 0.75
[Simplification of serial determination of phenol red]. Med Lab (Stuttg) (1965) 0.75
Effect of intravenous glibornuride and tolbutamide on myocardial contractility. Cardiology (1979) 0.75
Moclobemide versus clomipramine in nonmelancholic, nonpsychotic major depression. A Study group. Acta Psychiatr Scand (1995) 0.75
[The pharmacokinetics and metabolism of flunitrazepam]. Klin Anasthesiol Intensivther (1978) 0.75